ARHN Stock UPDATES Archon Corporation (ARHN) 17.0000 08/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Archon Corporation (ARHN) 17.0000 $ARHN

Esplanade Capital Raises Offer for Archon Corporation to $21.65 per Share
Marketwire - Wed Aug 27, 9:01AM CDT
Esplanade Capital LLC ("Esplanade" or "we" , the second largest outside shareholder (based on Bloomberg data) of Archon Corporation (PINKSHEETS: ARHN) ("Archon" or the "Company" , has raised its offer to acquire all outstanding shares of the Company to a price of $21.65 per share in a negotiated transaction, subject to confirmatory due diligence. Esplanade has delivered a letter to Archon's Board of Directors, the full text of which follows:

Esplanade Capital Raises Offer For Archon Corporation to $19.25 per Share
Business Wire - Thu Jan 16, 9:00AM CST
Esplanade Capital LLC, the second largest outside shareholder (based on Bloomberg data) of Archon Corporation (OTC: ARHN), has raised its offer to acquire all outstanding shares of Archon Corporation to a price of $19.25 per share in a negotiated transaction, subject to confirmatory due diligence. Esplanade Capital has delivered a letter to Archon's board of directors, the full text of which follows:

Esplanade Capital Raises Offer For Archon Corporation to $18.50 Per Share
Business Wire - Tue Jun 04, 9:00AM CDT
Esplanade Capital LLC, the second largest outside shareholder (based on Bloomberg data) of Archon Corporation (OTC: ARHN), has raised its offer to acquire all outstanding shares of Archon Corporation to a price of $18.50 per share in a negotiated transaction, subject to confirmatory due diligence. Esplanade Capital has delivered a letter to Archon's board of directors, the full text of which follows:

Lifshitz Law Firm Announces Investigation of Anaren, Inc., Archon Corporation, Life Technologies Corporation and National Financial Partners Corp.
PR Newswire - Mon Apr 22, 2:03PM CDT
Anaren, Inc.

Rigrodsky & Long, P.A. Announces Investigation Of Archon Corporation Proposed Buyout
Business Wire - Sat Apr 20, 12:05PM CDT
Rigrodsky & Long, P.A.:

Archon Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Board of Archon Corp. Concerning the Receipt of an Acquisition Proposal from Esplanade Capital
Business Wire - Thu Apr 18, 2:44PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating potential claims against the Board of Directors of Archon Corporation ("Archon" (OTC: ARHN) concerning the board's receipt of an acquisition proposal from Esplanade Capital, the second largest outside shareholder of Archon. Under the proposal, Esplanade Capital made an offer to acquire all of outstanding shares of Archon common stock for $17.50 per share.

Investor Alert: Former Attorney General of Louisiana and Kahn Swick & Foti, LLC Investigate Archon Corporation Following Announcement of Proposed Sale of Company to Esplanade Capital, LLC
Business Wire - Wed Apr 17, 12:09PM CDT
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC announce that KSF has commenced an investigation into the Board of Directors of Archon Corporation ("Archon" or the "Company) (OTC US: ARHN) in connection with their conduct related to the sale of the Company to Esplanade Capital, LLC, Archon's second largest outside shareholder. Under the terms of the proposed transaction, shareholders of Archon will receive $17.50 in cash for each share of Archon common stock that they own.

Faruqi & Faruqi, LLP is Investigating Archon Corporation (ARHN) for Potential Breaches of Fiduciary Duties
Business Wire - Tue Apr 16, 6:01PM CDT
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Archon Corporation ("Archon" or the "Company" (OTC US: ARHN) for potential breaches of fiduciary duties in connection with their conduct related to the proposed sale of the Company to Esplanade Capital LLC, the Company's second largest outside shareholder, in an all-cash deal valued at approximately $101 million. The proposed transaction offers Archon's shareholders $17.50 in cash for each share of Archon common stock they own.

Esplanade Capital Urges Board of Archon Corporation to Consider Its Offer to Acquire the Company
Business Wire - Mon Apr 15, 9:00AM CDT
Esplanade Capital LLC, the second largest outside shareholder (based on Bloomberg data) of Archon Corporation (OTC: ARHN), has made an offer to acquire all outstanding shares of Archon Corporation at a price of $17.50 per share in a negotiated transaction, subject to confirmatory due diligence. Esplanade Capital has delivered two letters to Archon's board of directors, the full texts of which follow:




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles